Girihlet Overview

  • Founded
  • 2012

  • Status
  • Private

  • Employees
  • 4

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $500K

  • Investors
  • 4

Girihlet General Information


Developer of patented sequencing technologies intended to purify and sequence mitochondrial DNA. The company's technology helps autoimmune patients monitor their immune systems to get guidance on appropriate therapies and treatment strategies, enabling researchers to have a significant impact in the clinic and get assisted in advanced basic research.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 2945 Webster Street
  • Oakland, CA 94609
  • United States
+1 (929) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Girihlet Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 09-Mar-2022 $500K 00.000 Completed Generating Revenue
3. Seed Round 09-Aug-2018 00.000 Completed Generating Revenue
2. Seed Round 09-Aug-2016 $2.5M $2.75M 00.000 Completed Generating Revenue
1. Accelerator/Incubator 03-Sep-2015 $250K $250K 00.000 Completed Generating Revenue
To view Girihlet’s complete valuation and funding history, request access »

Girihlet Cap Table

Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Girihlet’s complete cap table history, request access »

Girihlet Patents

Girihlet Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190055607-A1 Methods and compositions for determining specific tcr and bcr chain pairings Inactive 06-May-2016 0000000000
US-9868946-B2 Method of isolating pure mitochondrial dna Active 05-Nov-2012 00000000000 0
US-20150275200-A1 Method of isolating pure mitochondrial dna Active 05-Nov-2012 C12N15/1006

Girihlet Executive Team (2)

Name Title Board Seat Contact Info
Anitha Jayaprakash Ph.D Co-Founder, Chief Executive Officer & Board Member
Ravi Sachidanandam Ph.D Co-Founder, Chief Strategy Officer & Board Member
To view Girihlet’s complete executive team members history, request access »

Girihlet Board Members (4)

Name Representing Role Since
Anitha Jayaprakash Ph.D Girihlet Co-Founder, Chief Executive Officer & Board Member 000 0000
Ravi Sachidanandam Ph.D Girihlet Co-Founder, Chief Strategy Officer & Board Member 000 0000
You’re viewing 2 of 4 board members. Get the full list »

Girihlet Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Girihlet Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Digitalis Ventures Venture Capital Minority 000 0000 000000 0
SOSV Venture Capital Minority 000 0000 000000 0
True Ventures Venture Capital Minority 000 0000 000000 0
IndieBio Accelerator/Incubator Minority 000 0000 000000 0
To view Girihlet’s complete investors history, request access »